Delivery Order SPE2DX15D3404-SPE2DX24F1DCS
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$1.6K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of 4565927220 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical pharmaceutical product used for the treatment of opioid overdose. The $1,347.37 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on September 24, 2024. The contract type is a Delivery Order with a Firm Fixed Price, and the ultimate completion date is September 25, 2024. The contract does not have a...
This federal contract award is for the delivery of 4565321630 units of Naloxone HCL 4 mg Nasal Spray 2S, which is a critical medication used for the emergency treatment of opioid overdose. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,689.00 and is a Firm Fixed Price Delivery Order, with an ultimate completion...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,252.28, is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 24, 2025. The contract was not set aside for any specific...
This federal contract award, valued at $1,755.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used in the treatment of opioid overdose. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,170.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medical product used for the treatment of opioid overdose. The contract has an ultimate completion date of December 21, 2023, and is structured as a firm fixed-price delivery order, with no set-aside designation....
This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,288.70, is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. This is a firm fixed-price delivery order contract with a completion date of December 3, 2024. The contract was not set aside for any specific business type. AmerisourceBergen...
This federal contract award is for the delivery of 4,563,167,381 units of NALOXONE HCL 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract, valued at $5,347.15, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 21, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 22, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $2,667.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566961838 - NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of January 17, 2025. Amerisourcebergen holds a...
This federal contract award, valued at $1,838.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,999,320 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This delivery order contract has a firm fixed-price pricing type and an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp also...